Lipocine announces Health Canada approval of Tlando for testosterone replacement therapy
Lipocine said Health Canada approved its Tlando for testosterone replacement therapy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lipocine announces Health Canada approval of TLANDO for testosterone replacement therapy
Lipocine (LPCN) says Health Canada approved TLANDO for testosterone replacement therapy.